Eolas Medical Announces $12M Series A to Transform Access to Clinical Knowledge Worldwide

Eolas Medical (pronounced “o-las”, from the Irish word for knowledge) is excited to announce the close of its $12 million Series A round led by Munich based Acton Capital, with investment from Whiterock Capital, Portfolio Ventures, ScaleX Investments, Kindred Capital, Samaipata, and Ascension, whose renewed commitment reflects strong confidence in the company’s mission, momentum, and unique approach to reinventing how clinicians access medical knowledge.

‍

Solving a Global Problem: Accessing Critical Medical Knowledge

Every day, over 50 million healthcare professionals make 2 billion medical decisions across the globe, yet clinicians still struggle to find context specific medical knowledge at the point of care.

Hospitals and healthcare systems rely on thousands of guidelines, protocols, and policies. These vary between institutions. The information is fragmented, often buried across PDFs, shared drives, and intranets. The consequences are delayed decisions, inconsistent care, preventable errors, inefficiency, staff frustration, and unnecessary cost.

Eolas Medical exists to solve this problem. Its mission is clear: Make sure every healthcare professional can instantly and easily access the medical knowledge they need, exactly when they need it.

Eolas Medical already supports clinicians in more than 500 healthcare sites globally including in over 85% of acute NHS hospitals across the UK, over 40% of doctors in Ireland, and across major US health systems such as Stanford Healthcare and Massachusetts General Hospital. According to clinicians, the platform reduces up to 90% time spent searching for clinical knowledge, dramatically improving safety, efficiency, and adherence to best practices.

‍

“Our conversations with clinicians showed remarkable enthusiasm for Eolas,” says Fritz Oidtmann, Managing Partner at Acton Capital. “Clinicians love the product. The benefit is immediate, the value is clear, and this conviction and their unique positioning in the market strongly shaped our excitement to partner with Eolas Medical.”

‍

The Series A funding enables Eolas Medical to accelerate the development and global scale of its AI powered clinical knowledge platform. This investment will allow the company to expand its presence across the US, Europe and global healthcare systems and scale commercial, engineering, and clinical teams to meet international demand. Open roles and more information can be found on Eolas’ Careers page here.

‍

About Eolas Medical

Founded in 2020, Eolas Medical ( https://eolasmedical.com/ ) provides a clinical knowledge infrastructure platform that utilizes Artificial Intelligence (AI) to give clinicians instant access to institution specific guidelines, checklists and best practices at the point of care in an intuitive and easy to use interface. The platform centralizes all hospital approved content in one secure, searchable hub and is supported by an AI powered answer engine. Eolas Medical works with healthcare systems globally to improve clinical decision making and strengthen patient safety.

‍

About Acton

Acton Capital is an international venture capital firm located in Munich and Vancouver. Since 1999, the team has invested in technology-based business models from Europe and North America. With over two decades of experience and a deep understanding of digital transformation, Acton Capital has already supported over 100 startups in building successful businesses.

‍